Research suggests that targeting polyamine metabolism and ferroptosis may enhance the efficacy of KRAS-targeted therapy, with the effectiveness depending on KEAP1 status. The role of ferroptosis in cancer treatment is being explored in various studies, with potential applications in different types of cancer. The relationship between ferroptosis and cancer treatment is complex, with multiple molecular mechanisms and therapeutic strategies being investigated.